CVS polishes off deal to buy former Rite Aid stores
Digest more
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
We recently published Jim Cramer Discussed These 11 Stocks & The Market’s 3rd Bull Run Anniversary. CVS Health Corporation ...
CVS Health Corp’s stock reached a new 52-week high, closing at 79.21 USD, showcasing a strong performance in the market. The healthcare giant, with a market capitalization of $100.3 billion, has ...
--CVS Health Corporation today announced operating results for the three months ended March 31, 2025. For the three months ended March 31, 2025 compared to the prior year:. See pages 3 through 6 ...
Retail sales in the United States rose unexpectedly in August. According to a report by the Commerce Department, retail sales rose considerably faster than analysts’ estimates from July. They ...
CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey weight-loss shot, for more patients by allowing them to charge copays as ...
CVS Health (CVS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in ...
We recently published a list of Dividend Capture Strategy: 15 High Yield Stocks to Buy in April. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands ...
Second quarter total revenues increased to $98.9 billion, up 8.4% compared to prior year Second quarter GAAP diluted EPS of $0.80 and Adjusted EPS of $1.81 Generated year-to-date cash flow from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback